| scholarly article | Q13442814 |
| P50 | author | Jolene Windle | Q42708787 |
| Wei-Guo Zhu | Q42962893 | ||
| P2093 | author name string | Huiming Zhang | |
| Gregory A Otterson | |||
| Wenrui Duan | |||
| Gary D Stoner | |||
| Haiming Ding | |||
| Miguel A Villalona-Calero | |||
| Mark A Subler | |||
| P2860 | cites work | A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice | Q72293593 |
| Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53 | Q72871721 | ||
| Pharmacological rescue of mutant p53 conformation and function | Q73316566 | ||
| Human SP-C gene sequences that confer lung epithelium-specific expression in transgenic mice | Q73712501 | ||
| Thermodynamic stability of wild-type and mutant p53 core domain | Q24648879 | ||
| Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations | Q27730815 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| Oncogenic forms of p53 inhibit p53-regulated gene expression | Q28251120 | ||
| SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene | Q28281071 | ||
| Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours | Q29547697 | ||
| Tumor spectrum analysis in p53-mutant mice | Q29617436 | ||
| T antigen is bound to a host protein in SY40-transformed cells | Q29618321 | ||
| p53: puzzle and paradigm | Q29618407 | ||
| p53 mutant mice that display early ageing-associated phenotypes | Q29622826 | ||
| Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. | Q31041084 | ||
| Mutant p53: gain-of-function oncoproteins and wild-type p53 inactivators | Q33737277 | ||
| Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice | Q33738305 | ||
| Twenty years of p53 research: structural and functional aspects of the p53 protein | Q33807787 | ||
| A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database | Q34938323 | ||
| Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase | Q35323487 | ||
| High metastatic potential in mice inheriting a targeted p53 missense mutation | Q35673678 | ||
| Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding | Q36706865 | ||
| High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene | Q36760672 | ||
| The p53 tumour suppressor gene | Q37751892 | ||
| Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53 | Q38325583 | ||
| Loss of p19(ARF) eliminates the requirement for the pRB-binding motif in simian virus 40 large T antigen-mediated transformation | Q39455963 | ||
| Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain | Q39575066 | ||
| Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids | Q40021667 | ||
| Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells | Q40237209 | ||
| Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells | Q40281014 | ||
| Somatic activation of the K-ras oncogene causes early onset lung cancer in mice | Q40809826 | ||
| p53 and the Li-Fraumeni syndrome | Q40910310 | ||
| The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis | Q41211044 | ||
| Gain of function mutations in p53. | Q41557652 | ||
| Tumor suppressor p53: analysis of wild-type and mutant p53 complexes | Q41878071 | ||
| Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in transgenic mice. | Q52235415 | ||
| Similar incidence of K-ras mutations in lung carcinomas of FVB/N mice and FVB/N mice carrying a mutant p53 transgene. | Q53442036 | ||
| RT-PCR heteroduplex analysis permits differentiation of transgene and host gene expression in a transgenic animal model | Q57594686 | ||
| Wild-type p53 activates transcription in vitro | Q59054260 | ||
| An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53 | Q67539546 | ||
| Expression of SV40 T antigen under control of rabbit uteroglobin promoter in transgenic mice | Q67944833 | ||
| P433 | issue | 51 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 7831-7838 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic mice. | |
| P478 | volume | 21 |
| Q84583331 | 20 years studying p53 functions in genetically engineered mice |
| Q30485093 | A mouse model for EML4-ALK-positive lung cancer |
| Q28259527 | Cancer stem cells: the lessons from pre-cancerous stem cells |
| Q34560752 | Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells |
| Q34368432 | Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer. |
| Q41762183 | Expression of a mutant p53 results in an age-related demographic shift in spontaneous lung tumor formation in transgenic mice. |
| Q92761260 | Homologous recombination defects and how they affect replication fork maintenance |
| Q42520917 | Lung specific expression of a human mutant p53 affects cell proliferation in transgenic mice |
| Q33687048 | Mutant p53 gain-of-function in cancer |
| Q64892305 | Mutant p53 in cancer therapy-the barrier or the path. |
| Q34373621 | Oncomorphic TP53 Mutations in Gynecologic Cancers Lose the Normal Protein:Protein Interactions with the microRNA Microprocessing Complex |
| Q34775855 | TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma. |
| Q40106083 | p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells |
Search more.